Cerebrospinal fluid (CSF) markers such as Aβ42 (or Aβ42/40), phosphorylated tau (pTau), and total tau (tTau) reflect key aspects of AD pathology but struggle to fully capture its biological diversity or differentiate it from other dementias with overlapping pathologies.3, 4. This evidence concerns the gene MAPT and Alzheimer disease.